Log In
Print
BCIQ
Print
Print this Print this
 

Zovirax, acyclovir

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionNucleoside analog
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat recurrent herpes labialis in adults and adolescents
Regulatory Designation
Partner Renaissance Acquisition Holdings LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$300.0M

$300.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today